These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 8319729

  • 1. Liver transplantation for type I and type IV glycogen storage disease.
    Selby R, Starzl TE, Yunis E, Todo S, Tzakis AG, Brown BI, Kendall RS.
    Eur J Pediatr; 1993; 152 Suppl 1(Suppl 1):S71-6. PubMed ID: 8319729
    [Abstract] [Full Text] [Related]

  • 2. Liver transplantation for glycogen storage disease types I, III, and IV.
    Matern D, Starzl TE, Arnaout W, Barnard J, Bynon JS, Dhawan A, Emond J, Haagsma EB, Hug G, Lachaux A, Smit GP, Chen YT.
    Eur J Pediatr; 1999 Dec; 158 Suppl 2(Suppl 2):S43-8. PubMed ID: 10603098
    [Abstract] [Full Text] [Related]

  • 3. Failure of liver transplantation to diminish cardiac deposits of amylopectin and leukocyte inclusions in type IV glycogen storage disease.
    Rosenthal P, Podesta L, Grier R, Said JW, Sher L, Cocjin J, Watanabe F, Vasiliauskas E, van de Velde R, Makowka L.
    Liver Transpl Surg; 1995 Nov; 1(6):373-6. PubMed ID: 9346615
    [Abstract] [Full Text] [Related]

  • 4. Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis.
    Sokal EM, Van Hoof F, Alberti D, de Ville de Goyet J, de Barsy T, Otte JB.
    Eur J Pediatr; 1992 Mar; 151(3):200-3. PubMed ID: 1601012
    [Abstract] [Full Text] [Related]

  • 5. Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease.
    Starzl TE, Demetris AJ, Trucco M, Ricordi C, Ildstad S, Terasaki PI, Murase N, Kendall RS, Kocova M, Rudert WA.
    N Engl J Med; 1993 Mar 18; 328(11):745-9. PubMed ID: 8437594
    [Abstract] [Full Text] [Related]

  • 6. Glycogen storage disease type IV: a case report.
    Chan YJ, Lin SP, Chen BF.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct 18; 62(10):743-7. PubMed ID: 10533307
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Liver transplantation for type IV glycogen storage disease.
    Selby R, Starzl TE, Yunis E, Brown BI, Kendall RS, Tzakis A.
    N Engl J Med; 1991 Jan 03; 324(1):39-42. PubMed ID: 1984162
    [No Abstract] [Full Text] [Related]

  • 9. Natural history study of hepatic glycogen storage disease type IV and comparison to Gbe1ys/ys model.
    Koch RL, Kiely BT, Choi SJ, Jeck WR, Flores LS, Sood V, Alam S, Porta G, LaVecchio K, Soler-Alfonso C, Kishnani PS.
    JCI Insight; 2024 May 14; 9(12):. PubMed ID: 38912588
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports.
    Manzia TM, Angelico R, Toti L, Cillis A, Ciano P, Orlando G, Anselmo A, Angelico M, Tisone G.
    Transplant Proc; 2011 May 14; 43(4):1181-3. PubMed ID: 21620082
    [Abstract] [Full Text] [Related]

  • 12. Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease.
    McConkie-Rosell A, Wilson C, Piccoli DA, Boyle J, DeClue T, Kishnani P, Shen JJ, Boney A, Brown B, Chen YT.
    J Inherit Metab Dis; 1996 May 14; 19(1):51-8. PubMed ID: 8830177
    [Abstract] [Full Text] [Related]

  • 13. Modifiable factors affecting renal preservation in type I glycogen storage disease after liver transplantation: a single-center propensity-match cohort study.
    Chan YC, Liu KM, Chen CL, Ong AD, Lin CC, Yong CC, Tsai PC, Lu LS, Wu JY.
    Orphanet J Rare Dis; 2021 Oct 11; 16(1):423. PubMed ID: 34635148
    [Abstract] [Full Text] [Related]

  • 14. Reduced-size liver transplantation for glycogen storage disease.
    Ji HF, Wang WL, Shen Y, Zhang M, Liang TB, Wu J, Xu X, Yan S, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2009 Feb 11; 8(1):106-8. PubMed ID: 19208526
    [Abstract] [Full Text] [Related]

  • 15. The potential of dietary treatment in patients with glycogen storage disease type IV.
    Derks TGJ, Peeks F, de Boer F, Fokkert-Wilts M, van der Doef HPJ, van den Heuvel MC, Szymańska E, Rokicki D, Ryan PT, Weinstein DA.
    J Inherit Metab Dis; 2021 May 11; 44(3):693-704. PubMed ID: 33332610
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcome after liver transplantation in children with type 1 glycogen storage disease.
    Yuen WY, Quak SH, Aw MM, Karthik SV.
    Pediatr Transplant; 2021 Mar 11; 25(2):e13872. PubMed ID: 33044776
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fifteen years of follow-up of a liver transplant recipient with glycogen storage disease type Ia (Von Gierke disease).
    Maya Aparicio AC, Bernal Bellido C, Tinoco González J, Garcia Ruíz S, Aguilar Romero L, Marín Gómez LM, Suárez Artacho G, Alamo Martínez JM, Serrano Díez-Canedo J, Padillo Ruíz FJ, Gomez Bravo MA.
    Transplant Proc; 2013 Mar 11; 45(10):3668-9. PubMed ID: 24314991
    [Abstract] [Full Text] [Related]

  • 19. The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.
    Moses SW, Parvari R.
    Curr Mol Med; 2002 Mar 11; 2(2):177-88. PubMed ID: 11949934
    [Abstract] [Full Text] [Related]

  • 20. A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.
    Greene HL, Brown BI, McClenathan DT, Agostini RM, Taylor SR.
    Hepatology; 1988 Mar 11; 8(2):302-6. PubMed ID: 3162725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.